SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-034564
Filing Date
2024-03-14
Accepted
2024-03-14 17:00:22
Documents
20
Period of Report
2024-03-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm248506d2_8k.htm   iXBRL 8-K 35085
2 EXHIBIT 4.1 tm248506d2_ex4-1.htm EX-4.1 105343
3 EXHIBIT 10.1 tm248506d2_ex10-1.htm EX-10.1 111277
4 EXHIBIT 16.1 tm248506d2_ex16-1.htm EX-16.1 3554
8 GRAPHIC tm248506d2_ex16-1img001.jpg GRAPHIC 4192
9 GRAPHIC tm248506d2_ex16-1img002.jpg GRAPHIC 4947
10 GRAPHIC tm248506d2_ex16-1img003.jpg GRAPHIC 1140
  Complete submission text file 0001104659-24-034564.txt   497893

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA rzlt-20240308.xsd EX-101.SCH 3024
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE rzlt-20240308_lab.xml EX-101.LAB 34240
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rzlt-20240308_pre.xml EX-101.PRE 22365
21 EXTRACTED XBRL INSTANCE DOCUMENT tm248506d2_8k_htm.xml XML 3610
Mailing Address 275 SHORELINE DRIVE, SUITE 500 REDWOOD CITY CA 94065
Business Address 275 SHORELINE DRIVE, SUITE 500 REDWOOD CITY CA 94065 650-206-4507
Rezolute, Inc. (Filer) CIK: 0001509261 (see all company filings)

IRS No.: 273440894 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39683 | Film No.: 24751121
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)